相关实验视频

Updated: Jan 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

在4个低收入和中等收入国家的HEARTS高血压控制计划中,预算影响和投资案例

William Garcia¹, Obehioye Amiosior², Sohel Reza Choudhury³

¹Department of Global Health, University of Washington, Seattle, Washington, USA.

|December 10, 2025

概括

在低收入和中等收入国家扩大世界卫生组织HEARTS高血压 (HTN) 管理计划,预计到2040年将预防超过30万例死亡,为健康和经济带来重大利益.

科学领域:

公共卫生公共卫生
预防心血管疾病预防心血管疾病
卫生经济学卫生经济学

背景情况:

高血压 (HTN) 是心血管疾病的主要可修改风险因素,在低收入和中等收入国家没有最佳管理.
世界卫生组织的HEARTS计划提供了一种标准化的方法,以改善初级保健机构的HTN管理.

研究的目的:

为了模拟扩大HEARTS计划的计划成本和健康益处.
分析从2025年到2040年在孟加拉国,埃塞俄比亚,尼日利亚和菲律宾扩大HEARTS HTN治疗覆盖范围的影响.

主要方法:

利用心血管疾病模拟模型估计因增加HTN治疗覆盖率而避免的死亡和残疾.
收集的项目成本数据,包括工资,药物,诊断和基础设施,以国际美元 ($).
根据基本和替代成本情景,预计预算影响,健康益处和成本效益.

主要成果:

预计到2040年,在四个国家扩大HEARTS的成本将达到59亿美元,每个用户的成本从3美元到16美元不等.
到2040年,可以预防超过30万例死亡,其中孟加拉国 (120,000),尼日利亚 (77,500),菲律宾 (82,000) 和埃塞俄比亚 (47,200) 的死亡人数很大.
替代性成本场景表明,HEARTS计划的负担能力和经济回报可能有所改善.

结论:

预计扩大HEARTS高血压控制套餐将带来相当大的健康益处.
随着时间的推移, HEARTS 计划的扩展预计将产生显著的经济效益.

关键词:

他们的心脏.世界卫生组织世界卫生组织.预算影响预算影响费用费用费用费用费用费用控制高血压控制高血压投资案例投资案例投资案例

更多相关视频

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

相关概念视频

Hypertension I: Introduction

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...

Errors occurring during blood pressure monitoring

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...